The test measures two proteins that are linked to amyloid plaques in the brain, which are among the hallmarks of Alzheimer's.

The new test, known as the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, detects amyloid plaques through blood testing, a ...

While Alzheimer's disease is mostly considered a disorder of the brain, emerging evidence suggests that the condition also affects other organs of the body. Working with the laboratory fruit fly, ...

Sex-based differences in microglia could help explain patterns in brain diseases. For example, Alzheimer’s affects more women ...

PME-1 is a protein that modifies other proteins by removing methyl groups, but high levels of PME-1 are observed in some diseases, including Alzheimer's disease (AD) and cancer.

A new study published in Aging Cell has identified a promising molecule that may help reverse cognitive decline associated ...

While conditions like stress and depression have been previously linked to the brain-gut connection, a 2023 study from the ...

Studies suggest that the shingles vaccine may help reduce the risk of dementia, especially in older adults. With no cure for ...

Researchers at the University of Pittsburgh School of Medicine have made an important breakthrough in understanding Alzheimer ...

A team of Melbourne scientists have been backed by the Commonwealth Government’s Medical Research Future Fund (MRFF) Stem ...

Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...

The United States on Friday approved the first blood test for Alzheimer's, a move that could help patients begin treatment ...